Total (n = 118) | EVD-affected (n = 55) | EVD-unaffected (n = 58) | p value | |
---|---|---|---|---|
n (%, 95% CI) | n (%, 95% CI) | n (%, 95% CI) | ||
Facility type | ||||
Health centres | 47 (39.8, 31.0–48.7) | 24 (41.4, 28.7–54.1) | 23 (38.3, 26.0–50.6) | 0.74 |
Hospitals | 17 (14.4, 8.0–20.7) | 11 (19.0, 8.9–29.1) | 6 (10.0, 2.4–17.6) | 0.18 |
Health posts | 54 (45.8, 36.8–54.8) | 23 (39.7, 27.1–52.2) | 31 (51.7, 39.0–64.3) | 0.20 |
RDT availabilitya | 82 (78.1, 70.2–86.0) | 40 (76.9, 65.5–88.4) | 42 (79.3, 68.3–90.2) | 0.78 |
Anti-malarial drug availabilitya | 78 (72.8, 64.5–81.3) | 40 (75.5, 63.9–87.1) | 38 (70.4, 58.2–82.6) | 0.56 |
PPE availability | ||||
Glovesa | 82 (78.1, 70.2–86.0) | 39 (75.0, 63.2–86.8) | 43 (81.1, 70.6–91.7) | 0.45 |
Adequate PPEb | 29 (26.6, 18.3–34.9) | 20 (37.0, 24.2–49.9) | 9 (16.4, 6.6–26.1) | 0.02 |
Full PPEc | 7 (6.4, 1.8–11.0) | 6 (11.1, 2.7–19.5) | 1 (1.8, 0.0–5.4) | 0.09 |
Health workers reporting EVD case(s) | 24 (20.5, 13.2–27.8) | 19 (32.8, 20.7–44.8) | 5 (8.5, 1.4–15.6) | 0.0024 |